Who to call at CGBIO, and when
Fundz watches for the moments CGBIO starts buying, and tells you who to reach.
- An alert the day CGBIO raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at CGBIO, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at CGBIO. With Fundz connected, it knows.
CGBIO Forms Partnership with Sunyu Medical to Enter China's Regenerative Medicine Market.
Contract Type
partnership
Description
CGBIO has partnered with Sunyu Medical to expand its reach into the Chinese regenerative medicine market. This collaboration aims to leverage both companies' expertise and resources to develop advanced medical solutions for patients.
Quick answer
CGBIO Forms Partnership with Sunyu Medical to Enter China's Regenerative Medicine Market. (June 9, 2025). CGBIO is based in South Korea.
- What agreement did CGBIO announce on June 9, 2025?
- CGBIO has partnered with Sunyu Medical to expand its reach into the Chinese regenerative medicine market. This collaboration aims to leverage both companies' expertise and resources to develop advanced medical solutions for patients.
- What does CGBIO do?
- CGBIO is a leading biotechnology firm specializing in regenerative medicine.
- Where is CGBIO based?
- CGBIO is based in South Korea.
Source: Fundz verified event record.
Agreement Insights
What this usually meansCGBIO signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.